
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$284.3m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.68
7D
9.8%
1Y
658.4%
Clinuvel Pharmaceuticals
Market Cap: AU$451.8m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$8.96
7D
-2.8%
1Y
-17.9%